HC Wainwright Weighs in on Opus Genetics Q1 Earnings
Opus Genetics, Inc. (NASDAQ:IRD – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 EPS estimates for shares of Opus Genetics in a note issued to investors on Tuesday, April 1st. HC Wainwright analyst M. Caufield expects that the company will post earnings of ($0.34) per share for the quarter. HC Wainwright […]
